Innovative annatto-based therapy shows promise for treating pediatric halitosis

A study by researchers working in Brazil shows that antimicrobial photodynamic therapy in which blue light targets annatto colorant is a feasible and effective option for treatment of halitosis in mouth-breathing children.

Meitheal gains US commercial rights for CABP treatment therapy

XENLETA is intended to treat community-acquired bacterial pneumonia in the adult population. Credit: New Africa/Shutterstock. Meitheal Pharmaceuticals has gained exclusive US commercial rights for a

December 12, 2024

Early smoking tied to increased respiratory problems in young adults

People who started smoking under the age of 18 are more likely to experience respiratory symptoms, such as wheezing and phlegm, in their 20s, according

September 10, 2024

Ketogenic diet boosts IVF success for women with PCOS, study reveals

A recent study in the journal “Nutrients” investigated the effects of dietary interventions, including the Mediterranean diet (MD) and a very low-calorie ketogenic diet (VLCKD),

October 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.